Facility consolidation CAPS is closing multiple facilities in 2026, signaling a strategic reduction in footprint and potential interest in outsourcing contracts or ramped-up support for remaining sites to maintain capacity and continuity.

Expansion opportunity Despite closures, CAPS maintains the largest 503A network and 503B facilities; sales teams can target hospitals and outpatient facilities seeking scalable, compliant admixture and batch compounding solutions across multiple regions.

Leadership in outsourcing As the nation’s largest outsourcing admixture network with 28 years of experience, CAPS offers established reliability and safety credentials that can be highlighted to win new accounts facing supply volatility or regulatory scrutiny.

Strategic partnerships Past partnerships with industry players like Becton, Dickinson, and Co. suggest openness to collaboration; identify opportunities to propose co-managed sterile compounding programs or integrated supply chain solutions.

Financial scalability With revenue in the mid-range of hundreds of millions and a broad network, there is potential to upsell expanded services, including 503B batch compounding, sterile preparations, and nationwide service coverage to mid- to large-scale healthcare buyers.